Skip to content

Fibre-optic Guided Tracheal Intubation Through SADs

Fibre-optic Guided Tracheal Intubation Through Supraglottic Airway Devices - a Randomised Comparison Between I-gel and the LMA ProtectorTM

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03118596
Enrollment
180
Registered
2017-04-18
Start date
2017-05-24
Completion date
2018-03-26
Last updated
2020-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intubation; Difficult or Failed, Laryngeal Masks, Airway Management

Keywords

intubation, tracheal, airway device, supra-glottic airway device, fibreoptic scope

Brief summary

The study aims to establish which of the two second generation Supraglottic Airway Devices, the I-gel or the the laryngeal ask airway (LMA) Protector, is best suited to be used as a conduit to fibreoptic bronchoscope assisted tracheal intubation. The primary outcome of this will be the time to complete the tracheal intubation.

Detailed description

Tracheal intubation through a supraglottic airway device (SAD) is a well-established technique in the management of patients with a difficult airway. The technique can be used in patients in whom difficult intubation is expected, or in situations when tracheal intubation using another method was not possible. It is now recommended that tracheal intubation through the SAD should be performed using a fibreoptic scope (a camera device) to minimise the risk of trauma to the airway, and that second generation SADs are used to minimise the risk of aspiration of gastric contents. There are two second generation SADs currently available which allow tracheal intubation: the I-gel and the LMA protector. The I-gel is a second generation supraglottic airway device widely used in anaesthesia and resuscitation. Fibreoptic intubation through the I-gel has been evaluated in a recent prospective study (1), with the first attempt success rate of 91.4%. In another study (2) of patients with predicted difficult airway, the success rate of the procedure at first attempt was 96%. LMA Protector is a recently introduced, improved version the LMA supreme - another second generation SAD. LMA supreme has been used in clinical practice for more than 10 years, however, tracheal intubation through the device was extremely difficult because of the small size of the breathing channel. The LMA Protector, has a larger breathing channel allowing the passage of an endotracheal tube. Compared to the I-gel, is has also got a larger gastric drainage tube. This allows easy suction in the event of regurgitation. Therefore, it appears to be superior to the I-gel in preventing the aspiration. But there are no studies comparing the ease of intubation through I-gel and LMA Protector The aim of this study is to compare the ease of performing the fibreoptic guided tracheal intubation through these two devices. Our hypothesis is that intubation through the I-gel is easier and quicker.

Interventions

DEVICEI-gel

Fibreoptic guided tracheal intubation is going to be performed through the I-gel supraglottic airway.

Fibreoptic guided tracheal intubation is going to be performed through the LMA Protector supraglottic airway.

Sponsors

University Hospitals Coventry and Warwickshire NHS Trust
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

• All patients aged above 18, presenting for elective surgical procedure, where a supraglottic airway device can be used and left in place throughout the duration of surgery and requiring tracheal intubation

Exclusion criteria

* Patients who are do not wish to take part * Patients with class II obesity (BMI \>40) * Patients below 18 years of age * American Society of Anaesthesiologists (ASA 3, 4 and 5) * Patients with mouth opening of less than 3 cm * Patients deemed to require awake intubation * Surgery involving head and neck region * Surgery requiring prone position

Design outcomes

Primary

MeasureTime frameDescription
Total Intubation Time to Perform Fibreoptic Intubationless than 3 minutesTime form insertion of bronchoscope through the supraglottic airway device to obtaining the capnography trace

Secondary

MeasureTime frameDescription
Number of Attempts at the SAD Placementless than 2 minutesNumber of attempts taken to successfully place the supraglottic airway device in the oropharynx
Number of Participants With Ease of Placement of the SADless than 2 minutesThe ease of placement of the SAD assessed by the investigator on a four point scale: 1. \- Easy 2. \- Moderate Difficulty 3- Severe Difficulty 4 - Failure
Number of Participants With First and Second Attempt at Tracheal Intubationless than 3 minutesNumber of attempts at tracheal intubation. A new attempt is defined as re-insertion of the fibreoptic bronchoscope through the SAD.
SAD Insertion Timeless than 1 minuteTime taken to insert the supra-glottic airway device measured from insertion into the mouth until the capnography trace is obtained
Time to Carinal Viewless than 1 minuteThe time from insertion of fibreoptic scope into the lumen of the SAD to the visualization of the carina.
Number of Participants With Type of Airway Maneuvers Performed During Tracheal Intubation,less than 3 minutesThe number of tube rotations performed during tracheal intubation
Number of Participants With Quality of the View of the Vocal Cords Seen Through the SADless than 3 minutesThe quality of the view of the vocal cords seen through the SAD. It will be assessed, according to the previously published system, as: grade I - full view of the vocal cord, II - partial view of the vocal cords including arytenoids, III - epiglottis only, IV - other (SAD cuff, pharynx, others)

Countries

United Kingdom

Participant flow

Participants by arm

ArmCount
I-gel
Fibreoptic guided tracheal intubation through I-gel I-gel: Fibreoptic guided tracheal intubation is going to be performed through the I-gel supraglottic airway.
90
LMA Protector
Fibreoptic guided tracheal intubation through Protector LMA Protector: Fibreoptic guided tracheal intubation is going to be performed through the LMA Protector supraglottic airway.
86
Total176

Baseline characteristics

CharacteristicLMA ProtectorTotalI-gel
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
31 Participants64 Participants33 Participants
Age, Categorical
Between 18 and 65 years
55 Participants112 Participants57 Participants
Age, Continuous54.7 years
STANDARD_DEVIATION 17
55 years
STANDARD_DEVIATION 15
55.7 years
STANDARD_DEVIATION 15
Race and Ethnicity Not Collected0 Participants
Region of Enrollment
United Kingdom
86 participants176 participants90 participants
Sex: Female, Male
Female
35 Participants74 Participants39 Participants
Sex: Female, Male
Male
51 Participants102 Participants51 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 920 / 86
other
Total, other adverse events
0 / 920 / 86
serious
Total, serious adverse events
0 / 920 / 86

Outcome results

Primary

Total Intubation Time to Perform Fibreoptic Intubation

Time form insertion of bronchoscope through the supraglottic airway device to obtaining the capnography trace

Time frame: less than 3 minutes

Population: In 2 patients randomly allocated to the LMA Protector group due to the failure insertion of the LMA protector the i-gel was used instead. 2 patients randomised to the LMA protector group underwent direct laryngoscopy and tracheal intubation; one due to failed insertion of both devices and one due to the failed fibreopitc-guided tracheal intubation

ArmMeasureValue (MEAN)Dispersion
I-gelTotal Intubation Time to Perform Fibreoptic Intubation54.3 secondsStandard Deviation 13.8
LMA ProtectorTotal Intubation Time to Perform Fibreoptic Intubation52.0 secondsStandard Deviation 13
Secondary

Number of Attempts at the SAD Placement

Number of attempts taken to successfully place the supraglottic airway device in the oropharynx

Time frame: less than 2 minutes

Secondary

Number of Participants With Ease of Placement of the SAD

The ease of placement of the SAD assessed by the investigator on a four point scale: 1. \- Easy 2. \- Moderate Difficulty 3- Severe Difficulty 4 - Failure

Time frame: less than 2 minutes

Population: In 2 patients randomly allocated to the LMA Protector group due to the failure insertion of the LMA protector the i-gel was used instead. 2 patients randomised to the LMA protector group underwent direct laryngoscopy and tracheal intubation; one due to failed insertion of both devices and one due to the failed fibreopitc-guided tracheal intubation

ArmMeasureGroupValue (NUMBER)
I-gelNumber of Participants With Ease of Placement of the SADEasy86 participants
I-gelNumber of Participants With Ease of Placement of the SADModerate Resistance6 participants
I-gelNumber of Participants With Ease of Placement of the SADSevere Resistance0 participants
I-gelNumber of Participants With Ease of Placement of the SADFailure0 participants
LMA ProtectorNumber of Participants With Ease of Placement of the SADFailure0 participants
LMA ProtectorNumber of Participants With Ease of Placement of the SADEasy37 participants
LMA ProtectorNumber of Participants With Ease of Placement of the SADSevere Resistance5 participants
LMA ProtectorNumber of Participants With Ease of Placement of the SADModerate Resistance44 participants
Secondary

Number of Participants With First and Second Attempt at Tracheal Intubation

Number of attempts at tracheal intubation. A new attempt is defined as re-insertion of the fibreoptic bronchoscope through the SAD.

Time frame: less than 3 minutes

Population: IIn 2 patients randomly allocated to the LMA Protector group due to the failure insertion of the LMA protector the i-gel was used instead. 2 patients randomised to the LMA protector group underwent direct laryngoscopy and tracheal intubation; one due to failed insertion of both devices and one due to the failed fibreopitc-guided tracheal intubation

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
I-gelNumber of Participants With First and Second Attempt at Tracheal IntubationFirst Attempt90 Participants
I-gelNumber of Participants With First and Second Attempt at Tracheal IntubationSecond Attempt2 Participants
LMA ProtectorNumber of Participants With First and Second Attempt at Tracheal IntubationFirst Attempt84 Participants
LMA ProtectorNumber of Participants With First and Second Attempt at Tracheal IntubationSecond Attempt2 Participants
Secondary

Number of Participants With Quality of the View of the Vocal Cords Seen Through the SAD

The quality of the view of the vocal cords seen through the SAD. It will be assessed, according to the previously published system, as: grade I - full view of the vocal cord, II - partial view of the vocal cords including arytenoids, III - epiglottis only, IV - other (SAD cuff, pharynx, others)

Time frame: less than 3 minutes

Population: In 2 patients randomly allocated to the LMA Protector group due to the failure insertion of the LMA protector the i-gel was used instead. 2 patients randomised to the LMA protector group underwent direct laryngoscopy and tracheal intubation; one due to failed insertion of both devices and one due to the failed fibreopitc-guided tracheal intubation

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
I-gelNumber of Participants With Quality of the View of the Vocal Cords Seen Through the SADGrade 171 Participants
I-gelNumber of Participants With Quality of the View of the Vocal Cords Seen Through the SADGrade 220 Participants
I-gelNumber of Participants With Quality of the View of the Vocal Cords Seen Through the SADGrade 31 Participants
LMA ProtectorNumber of Participants With Quality of the View of the Vocal Cords Seen Through the SADGrade 172 Participants
LMA ProtectorNumber of Participants With Quality of the View of the Vocal Cords Seen Through the SADGrade 214 Participants
LMA ProtectorNumber of Participants With Quality of the View of the Vocal Cords Seen Through the SADGrade 30 Participants
Secondary

Number of Participants With Type of Airway Maneuvers Performed During Tracheal Intubation,

The number of tube rotations performed during tracheal intubation

Time frame: less than 3 minutes

Population: In 2 patients randomly allocated to the LMA Protector group due to the failure insertion of the LMA protector the i-gel was used instead. 2 patients randomised to the LMA protector group underwent direct laryngoscopy and tracheal intubation; one due to failed insertion of both devices and one due to the failed fibreopitc-guided tracheal intubation

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
I-gelNumber of Participants With Type of Airway Maneuvers Performed During Tracheal Intubation,Tube impingement (Yes)38 Participants
I-gelNumber of Participants With Type of Airway Maneuvers Performed During Tracheal Intubation,Tube impingement (No)54 Participants
LMA ProtectorNumber of Participants With Type of Airway Maneuvers Performed During Tracheal Intubation,Tube impingement (Yes)23 Participants
LMA ProtectorNumber of Participants With Type of Airway Maneuvers Performed During Tracheal Intubation,Tube impingement (No)63 Participants
Secondary

SAD Insertion Time

Time taken to insert the supra-glottic airway device measured from insertion into the mouth until the capnography trace is obtained

Time frame: less than 1 minute

Population: In 2 patients randomly allocated to the LMA Protector group due to the failure insertion of the LMA protector the i-gel was used instead. 2 patients randomised to the LMA protector group underwent direct laryngoscopy and tracheal intubation; one due to failed insertion of both devices and one due to the failed fibreopitc-guided tracheal intubation

ArmMeasureValue (MEAN)Dispersion
I-gelSAD Insertion Time19.4 secondsStandard Deviation 5.6
LMA ProtectorSAD Insertion Time25.4 secondsStandard Deviation 7.9
Secondary

Time to Carinal View

The time from insertion of fibreoptic scope into the lumen of the SAD to the visualization of the carina.

Time frame: less than 1 minute

Population: In 2 patients randomly allocated to the LMA Protector group due to the failure insertion of the LMA protector the i-gel was used instead. 2 patients randomised to the LMA protector group underwent direct laryngoscopy and tracheal intubation; one due to failed insertion of both devices and one due to the failed fibreopitc-guided tracheal intubation

ArmMeasureValue (MEAN)Dispersion
I-gelTime to Carinal View23.4 secondsStandard Deviation 10
LMA ProtectorTime to Carinal View21.9 secondsStandard Deviation 8.3

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026